FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/26/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
ST13
US500000079398397Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Mark description
The mark consists of the wording "SERB PHARMACEUTICALS". The word "SERB" appears above the word "PHARMACEUTICALS". To the left of the wording is a circular shape resembling a donut.
Holders
Representatives
Sherry L. Rollo Hahn Loeser & Parks, LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for scientific use, other than for medical or veterinary use; Chemical substances for scientific use for analyses in laboratories, other than for medical or veterinary use; chemical preparations and substances with or without coloring agents for laboratory analyses, other than for medical or veterinary use; chemical preparations for scientific purposes other than for medical or veterinary use; diagnostic preparations and substances in the nature of chemicals with or without coloring agents other than for medical or veterinary use, namely, chemical diagnostic reagents for industrial purposes; chemical additives with or without coloring agents used in the composition of diagnostic preparations and substances, namely, chemical additives for use in the manufacture of pharmaceuticals; chemical reagents with or without coloring agents, other than for medical or veterinary use, namely, chemical reagents for non-medical purposes; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of snake bite venom, the treatment of digoxin toxicity and overdose, the treatment of methotrexate toxicity and overdose, the treatment of exposure to nuclear radiation and the treatment of cyanide poisoning.
Class 5
Pharmaceutical preparations, medicines and substances, namely, pharmaceutical preparations for treating poisonings, overdoses of any type, allergies, snake bites, exposure to nuclear radiations, infections, tumors, heart diseases, blood diseases, skin diseases, gastric diseases, liver diseases, neurological diseases, ophthalmological diseases, lung diseases, rheumatological diseases, rare ocular diseases; Pharmaceutical preparations for the treatment of snake bite venom; Pharmaceutical preparations for the treatment of digoxin toxicity and overdose; Pharmaceutical preparations for the treatment of methotrexate toxicity and overdose; Pharmaceutical preparations, namely, potassium iodide, for the treatment of exposure to nuclear radiation; Pharmaceutical preparations for the treatment of cyanide poisoning; Antidotes; veterinary preparations, medicines and substances, namely, veterinary preparations of snake bite venom to treat snake bites, veterinary preparations for the treatment of digoxin toxicity and overdose, veterinary preparations for the treatment of methotrexate toxicity and overdose, veterinary preparations for the treatment of cyanide poisoning; Biological preparations for medical, pharmaceutical and veterinary use, namely, biological preparations for the treatment of cancer; radioactive substances for medical use; dietetic beverages and foods adapted for medical use; nutritional supplements for medical use; diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary use; radiological contrast substances for medical use; herbal tinctures for medical use; surgical implants made of living tissue; medical and veterinary microbial media, namely, cell culture media for medical and veterinary use; cultures of microorganisms for medical or veterinary use; antibiotic preparations; dressings for medical use.
Class 10
Surgical apparatus and instruments for medical, dental and veterinary use; infusion apparatus for therapeutic use; thermometers for medical use; Artificial implants, namely, implants consisting of artificial materials; stents; Dental prostheses; cardiac pacemakers; lenses in the nature of intraocular prostheses for surgical implantation; Orthopedic articles, namely, orthopedic braces for the prevention and the correction of disorders of the musculoskeletal system affecting bones, joints, muscles, tendons and nerves; x-ray apparatus for medical use; Electromagnetic medical diagnostic imaging apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic equipment, namely, diagnostic penlights for medical purposes
Class 42
Medical research services; Scientific research for medical use; pharmaceutical diagnostic testing services, namely, testing of pharmaceuticals; pharmaceutical diagnostic testing services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals; Research and development of new products; assessment in scientific and technical fields provided by engineers, namely, consulting in the field of engineering; Appraisals in the fields of science and technology provided by engineers, namely, conducting scientific feasibility studies; scientific research; Technical and scientific studies, namely, conducting scientific feasibility studies
Class 44
Medical services; medical assistance; veterinary services; consultation with respect to pharmacy, namely, pharmaceutical consultation.
History of USPTO decisions and trademark events.
36 publications found
FINAL DECISION TRANSACTION PROCESSED BY IB
02/26/2026
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2026
FINAL DISPOSITION PROCESSED
02/06/2026
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/26/2025
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/15/2025
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/15/2025
REGISTERED-PRINCIPAL REGISTER
07/15/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/27/2025
PUBLISHED FOR OPPOSITION
05/27/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/21/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2025
EXAMINER'S AMENDMENT ENTERED
04/29/2025
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/29/2025
EXAMINERS AMENDMENT E-MAILED
04/29/2025
EXAMINERS AMENDMENT -WRITTEN
04/29/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
04/24/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/24/2025
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/24/2025
NEW REPRESENTATIVE AT IB RECEIVED
01/23/2025
NOTIFICATION OF FINAL REFUSAL EMAILED
01/03/2025
FINAL REFUSAL E-MAILED
01/03/2025
FINAL REFUSAL WRITTEN
01/03/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/30/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/30/2024
REFUSAL PROCESSED BY IB
09/09/2024
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/20/2024
REFUSAL PROCESSED BY MPU
08/20/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/13/2024
NON-FINAL ACTION WRITTEN
08/12/2024
ASSIGNED TO EXAMINER
08/09/2024
APPLICATION FILING RECEIPT MAILED
07/01/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2024
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/27/2024
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.